(Q30985612)

28 June 2017

1 reference

title

Polycystic ovary syndrome, hyperandrogenism, and insulin resistance (English)

1 reference

polycystic ovary syndrome

28 June 2017

1 reference

1 reference

1 reference

1 reference

Zacur HA

1

1 reference

PubMed ID

11293002

28 June 2017

language of work or name

1 reference

1 March 2001

1 reference

Obstetrics and Gynecology Clinics of North America

28 June 2017

1 reference

28 June 2017

28

1 reference

28 June 2017

1

1 reference

28 June 2017

21-33

1 reference

Insulin enhancement of luteinizing hormone and follicle-stimulating hormone release by cultured pituitary cells

28 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Regulation of extragonadal insulin-like growth factor-binding protein-3 by testosterone in oophorectomized women

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

1 reference

7 January 2021

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

1 reference

7 January 2021

Effects of insulin on steroidogenesis in cultured porcine ovarian theca

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Body composition and regional fat distribution in polycystic ovarian syndrome. Relationship to hormonal and metabolic profiles.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Correlation of hyperandrogenism with hyperinsulinism in polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Insulin-like growth factor I and insulin potentiate luteinizing hormone-induced androgen synthesis by rat ovarian thecal-interstitial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Insulin resistance in nonobese patients with polycystic ovarian disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Lack of insulin resistance in fibroblasts from subjects with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Impaired glucose transport as a cause of decreased insulin-stimulated muscle glycogen synthesis in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Effect of Acute Physiological Elevations of Insulin on Circulating Androgen Levels in Nonobese Women*

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Characterization of groups of hyperandrogenic women with acanthosis nigricans, impaired glucose tolerance, and/or hyperinsulinemia

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Excessive insulin receptor serine phosphorylation in cultured fibroblasts and in skeletal muscle. A potential mechanism for insulin resistance in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

The insulin-sensitizing agent troglitazone improves metabolic and reproductive abnormalities in the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Polycystic ovary syndrome as a form of functional ovarian hyperandrogenism due to dysregulation of androgen secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Persistence of insulin resistance in polycystic ovarian disease after inhibition of ovarian steroid secretion.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Banting Lecture. Insulin action, diabetogenes, and the cause of type II diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Insulin stimulates the phosphorylation of the 95,000-dalton subunit of its own receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Normal endothelial function despite insulin resistance in healthy women with the polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Troglitazone-induced fulminant hepatic failure. Acute Liver Failure Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

The effects of hyperinsulinemia on serum testosterone, progesterone, dehydroepiandrosterone sulfate, and cortisol levels in normal women and in a woman with hyperandrogenism, insulin resistance, and acanthosis nigricans

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Ovulatory and metabolic effects of D-chiro-inositol in the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

A direct effect of hyperinsulinemia on serum sex hormone-binding globulin levels in obese women with the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Troglitazone-induced hepatic failure leading to liver transplantation. A case report

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Medical hazards of obesity

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Mortality of women with polycystic ovary syndrome at long-term follow-up

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

The effects of experimental hyperinsulinemia on steroid secretion, ovarian [125I]insulin binding, and ovarian [125I]insulin-like growth-factor I binding in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Obesity associated with a mutation in a genetic regulator of adipocyte differentiation

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Thiazolidinediones: an update.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Glucose transporters and insulin action--implications for insulin resistance and diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Phosphoinositide 3-kinase: the key switch mechanism in insulin signalling

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Insulin resistance in polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Coronary heart disease risk factors in women with polycystic ovary syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Overexpression of a constitutively active form of phosphatidylinositol 3-kinase is sufficient to promote Glut 4 translocation in adipocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Linkage and association of insulin gene VNTR regulatory polymorphism with polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Cardiovascular disease in women with polycystic ovary syndrome at long-term follow-up: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Guidelines for healthy weight

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Serine phosphorylation of human P450c17 increases 17,20-lyase activity: implications for adrenarche and the polycystic ovary syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

Polycystic ovary syndrome: lack of hypertension despite profound insulin resistance.

1 reference

https://api.crossref.org/works/10.1016%2FS0889-8545%2805%2970183-2

7 January 2021

10.1016/S0889-8545(05)70183-2

Identifiers

DOI

1 reference

28 June 2017

1 reference

PubMed ID

11293002